CC
KRTX

Centiva Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Centiva Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,200
Closed -$6.39M – 2395
2023
Q4 		$6.39M Buy
+20,200
New +$3.93M 0.15% 118

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Centiva Capital's KRTX Position: Q1 2024 in Review

Centiva Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 15,036 shares — an estimated $4.76M sold.

Centiva Capital first reported a position in KRTX in Q2 2023 and held it in 2 quarters. The position peaked at $4.76M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Centiva Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Centiva Capital sold 15,036 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.76M.
  • Centiva Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Centiva Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $4.76M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Centiva Capital's 13F filing for Q1 2024, filed 15 May 2024.